🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Contribution of 3D Modeling in Surgical Management of Pediatric Retroperitoneal and Pelvic Tumors

Recruitingn/aAges 3 Months - 17 YearsAllAssistance Publique - Hôpitaux de Paris
NCT06418243 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study's purpose is the comparison of the automatically segmented 3D model to the reference manual segmentation, based on the Dice precision index. It is implemented by making parents' patients, surgeons and surgical helpers answer specific questions comparing 3D images to usual 2D images of the patient's tumor.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Children: * Children between 3 months and less than 18 years old * Children with a pelvic tumor requiring an MRI for a possible surgical intervention * Children with a retroperitoneal tumor requiring a CT scan or MRI with a view to surgical intervention * Children with no contraindication for a CT scan and/or 3T MRI * Children whose parents do not object to their participation in the study Other participants: * Operating surgeon agreeing to participate in the study * Caregiver agreeing to participate in the study * External surgeon agreeing to participate in the study Exclusion Criteria: Children : * Contraindication to MRI: metallic ocular foreign body, pacemaker, mechanical heart valve, old vascular clips on cerebral aneurysm * Need for an MRI under general anaesthesia * Contraindication for a CT scan with injection: renal failure, allergy to iodinated contrast products * Patients having participated in a therapeutic clinical trial involving a new molecule within 30 days before inclusion * Emergency situation
💊

What it tests

  • Not listed
📍

Where

1 site
Hôpital Necker Enfants Malades. Service de Chirurgie Viscérale et Urologie pédiatrique
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy